| Die meistzitierten Artikel | Die meistzitierten Reviews | Die meistzitierten Köpfe |
Bild der meistzitierten Köpfe |
||
Die meistzitierten Artikel |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Manns MP, ..., Albrecht JK | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial LANCET 358 (9286): 958-965 SEP 22 2001 | 1197 |
| 2. | Fried MW, ..., Häussinger D, ..., Hoffman J, Yu J | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. NEW ENGLAND JOURNAL OF MEDICINE 347 (13): 975-982 SEP 26 2002 | 903 |
| 3. | Zeuzem S, ..., Rasenack J, ..., Hoffman J, Brunda MJ | Peginterferon alfa-2a in patients with chronic hepatitis C NEW ENGLAND JOURNAL OF MEDICINE 343 (23): 1666-1672 DEC 7 2000 | 490 |
| 4. | Hanauer SB, ..., Mayer LF, Schreiber S, ..., Rutgeerts P | Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial LANCET 359 (9317): 1541-1549 MAY 4 2002 | 383 |
| 5. | Hampe J, ..., Croucher PJ, ..., Mascheretti S, ..., Nikolaus S, ..., Fölsch UR, Krawczak M, ..., Schreiber S, Mathew CG | Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations LANCET 357 (9272): 1925-1928 JUN 16 2001 | 382 |
| 6. | Steidler L, ..., Obermeier F, Falk W, ..., Remaut E | Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 SCIENCE 289 (5483): 1352-1355 AUG 25 2000 | 314 |
| 7. | Lindsay KL, ..., Heintges T, ..., Albrecht JK | A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C HEPATOLOGY 34 (2): 395-403 AUG 2001 | 256 |
| 8. | Cario E, Podolsky DK | Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease INFECTION AND IMMUNITY 68 (12): 7010-7017 DEC 2000 | 253 |
| 9. | Cuthbert AP, ..., Hampe J, Croucher PJ, Mascheretti S, ..., Schreiber S, Lewis CM, Mathew CG | The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease GASTROENTEROLOGY 122 (4): 867-874 APR 2002 | 242 |
| 10. | Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP, Rehermann B | Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C NATURE MEDICINE 6 (5): 578-582 MAY 2000 | 242 |
Die meistzitierten Reviews |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Malfertheiner P, ..., Wadstrom T | Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report ALIMENTARY PHARMACOLOGY & THERAPEUTICS 16 (2): 167-180 FEB 2002 | 469 |
| 2. | Bartenschlager R, Lohmann V | Replication of hepatitis C virus. J. GEN. VIROLOGY 81: 1631-1648 Part 7 JUL 2000 | 208 |
| Tilg H, Diehl A | Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis NEW ENGLAND JOURNAL OF MEDICINE 343 (20): 1467-1476 NOV 16 2000 | 196 | |
Die meistzitierten Köpfe |
||||
| Rang | Name | Ort | Zitierungen | Artikel |
| 1 | Michael P. Manns | Gastr. Hepat. & Endokr., MH Hannover | 4941 | 198 |
| 2 | Stefan Schreiber | Muc. Immunol., Allg. Inn. Med., Uni Kiel | 2694 | 61 |
| 3 | Peter J. Meier-Abt | Klin. Pharmakol. & Toxikol., Uni Zürich | 2387 | 62 |
| 4 | Jürgen Schölmerich | Gastroent., Klinik Inn. Med., Uni Regensburg | 2169 | 168 |
| 5 | Dieter Häussinger | Gastroent., Hepat. & Infekt., Uni Düsseldorf | 2084 | 101 |
| 6 | Manfred Stolte | Inst. Pathologie, Klinik Bayreuth/ Uni Erlangen | 1857 | 102 |
| 7 | Eckhart G. Hahn | Inn. Med. & Gastroent., Uni Erlangen | 1782 | 195 |
| 8 | Stefan Zeuzem | Inn. Med., Uni Homburg (bis 6'2002 Uni Frankfurt) | 1734 | 74 |
| 9 | Guido Adler | Klin. Chem. & Pathobiochem., Inn. Med., Uni Ulm | 1598 | 88 |
| 10 | Peter R. Galle | Inn. Med. I, Uniklinik Mainz | 1557 | 83 |
| 11 | Christian Trautwein | Gastroent., Hepat. & Endokr., MH Hannover | 1533 | 57 |
| 12 | Hubert E. Blum | Inn. Med. II, Uniklinik Freiburg | 1479 | 65 |
| 13 | Bruno Stieger | Klin. Pharmakol. & Toxikol., Uni Zürich | 1408 | 42 |
| 14 | Hans G. Beger | Klin. Chem. & Pathobiochem., Uni Ulm | 1376 | 99 |
| 15 | Dietrich Keppler | Tumorbiochem., DKFZ Heidelberg | 1276 | 32 |
| 16 | Tilman Sauerbruch | Allg. Inn. Med., Uniklinik Bonn | 1258 | 128 |
| 17 | Ulrich R. Fölsch | Mol. Gastroent., Allg. Inn. Med., Uni Kiel | 1243 | 61 |
| 18 | Jochen Hampe | Med. I, Uniklinik Kiel & Klin. Mol. Biol., Uni Kiel | 1205 | 29 |
| 19 | Bertram J. Wiedenmann | Gastroent., Hepat. & Endokr., HU Berlin | 1173 | 64 |
| 20 | Ralf F. Bartenschlager | Mol. Virol., Uni Heidelberg (bis 2001 Mainz) | 1156 | 18 |
| 21 | Gerd R. Pape | Gastroent. & Hepat., Med. Klinik, LMU München | 1134 | 25 |
| 22 | Markus F. Neurath | Immunol., Med. Klinik, Uni Mainz | 1130 | 30 |
| 23 | Susanna Nikolaus | Mucosal Immunol., Allg. Inn. Med., Uni Kiel | 1072 | 19 |
| 24 | Wolfram Domschke | Med. Klinik, Uni Münster | 1071 | 84 |
| 25 | Gerd A. Kullak-Ublick | Gastroent. & Hepat., Unispital Zürich | 1062 | 31 |
| 26 | Norbert H. Grüner | Immunol. & Med. Klinik, LMU München | 1043 | 16 |
| 27 | Silvia Mascheretti | Mucosal Immunol., Allg. Inn. Med., Uni Kiel | 947 | 11 |
| 28 | Volker Lohmann | Mol. Virol., Uni Heidelberg (bis 2001 Virol. Mainz) | 933 | 12 |
| 29 | Peter J. P. Croucher | Allg. Inn. Med., Uni Kiel | 930 | 9 |
| 30 | Peter Malfertheiner | Gastroent., Hepat. & Infekt., Uni Magdeburg | 905 | 104 |
| 31 | Detlef Schuppan | (seit 2004 Boston) Gastroent., Uni Erlangen | 865 | 78 |
| 32 | Herbert Lochs | Gastroent., Hepat. & Endokr., HU Berlin | 861 | 57 |
| 33 | Alfred Gangl | Gastroent. & Hepat., Inn. Med., Uniklinik Wien | 830 | 45 |
| 34 | Wolff H. Schmiegel | Gastroent. & Hepat., Med. Klinik, Uni Bochum | 797 | 39 |
| 35 | Jürg Reichen | Inst. Klin. Pharmakol., Uni Bern | 794 | 22 |
| Christian Ell | Inn. Med., Dr Horst Schmidt Kliniken Wiesbaden | 794 | 33 | |
| 37 | Bruno Hagenbuch | (seit 2005 Kansas) Inn. Med., Unispital Zürich | 781 | 20 |
| 38 | Peter Ferenci | Gastroent. & Hepat., Inn. Med., Uniklinik Wien | 771 | 42 |
| 39 | Jens W. Rasenack | Gastroent., Hepat. & Endokr., Uniklinik Freiburg | 755 | 14 |
| 40 | Peter C. Konturek | Gastroent., Med. Uniklinik Erlangen | 753 | 71 |
| 41 | Karin Fattinger | Klin. Pharmakol. & Toxikol., Uni Zürich | 747 | 19 |
| 42 | Ernst-Otto Riecken | Gastroent. & Infekt., Med. Klinik FU Berlin | 745 | 41 |
| 43 | Wolfgang Stremmel | Inn. Med., Uniklinik Heidelberg | 742 | 69 |
| 44 | Darius Moradpour | (seit 9'2004 Lausanne) Inn. Med. II, Uni Freiburg | 739 | 18 |
| 45 | Kurt Zatloukal | Pathol. Uni Graz | 735 | 23 |
| 46 | J.-Matthias Löhr | Gastroent., Med. Uni Mannheim (bis 2000 Rostock) | 723 | 28 |
| 47 | Ulrich Spengler | Med. Klinik Uni Bonn | 722 | 65 |
| 48 | Joachim Mössner | Med. Klinik Uni Leipzig | 705 | 51 |
| 49 | Arthur Zimmermann | Pathol., Inselspital, Uni Bern | 703 | 71 |
| 50 | Hans Will | Heinrich-Pette-Inst. Exp. Virol. & Immunol., Uni Hamburg | 699 | 29 |